EP0532190 - Benzo(f)quinolinones as 5-alpha-reductase inhibitors [Right-click to bookmark this link] | |||
Former [1993/11] | Benzo f quinolinones as 5-alpha-reductase inhibitors | ||
[2000/15] | Status | No opposition filed within time limit Status updated on 02.11.2001 Database last updated on 02.08.2024 | Most recent event Tooltip | 02.11.2001 | No opposition filed within time limit | published on 19.12.2001 [2001/51] | Applicant(s) | For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, IN 46285 / US | [N/P] |
Former [1993/11] | For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, Indiana 46285 / US | Inventor(s) | 01 /
Audia, James Edmund 6649 Lakeside Woods Circle Indianapolis, Indiana 46278 / US | 02 /
Hirsch, Kenneth Steven 6473 Haviland Mill Road Clarksville, Maryland 21029 / US | 03 /
Jones, Charles David 223 East Brunswick Avenue Indianapolis, Indiana 46227 / US | 04 /
Lawhorn, David Ernest 709 Noth Wilson Street Greenfield, Indiana 46254 / US | 05 /
McQuaid, Loretta Ames 7504 Runningbrook Court Indianapolis, Indiana 46254 / US | 06 /
Weigel, Leland Otto 4927 Cherry Hill Lane Indianapolis, Indiana 46254 / US | [1993/11] | Representative(s) | Tapping, Kenneth George, et al Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham Surrey GU20 6PH / GB | [N/P] |
Former [1993/11] | Tapping, Kenneth George, et al Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham Surrey GU20 6PH / GB | Application number, filing date | 92307637.6 | 20.08.1992 | [1993/11] | Priority number, date | US19910748116 | 21.08.1991 Original published format: US 748116 | US19910781039 | 21.10.1991 Original published format: US 781039 | US19920927710 | 10.08.1992 Original published format: US 927710 | [1993/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0532190 | Date: | 17.03.1993 | Language: | EN | [1993/11] | Type: | A3 Search report | No.: | EP0532190 | Date: | 14.07.1993 | Language: | EN | [1993/28] | Type: | B1 Patent specification | No.: | EP0532190 | Date: | 27.12.2000 | Language: | EN | [2000/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.05.1993 | Classification | IPC: | C07D221/10, C07C229/46, C07C49/747, A61K31/435 | [1993/11] | CPC: |
C07D221/10 (EP,US);
C07D215/06 (KR);
A61P13/08 (EP);
A61P17/00 (EP);
A61P17/08 (EP);
A61P17/10 (EP);
A61P17/14 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07C227/16 (EP,US);
C07C229/46 (EP,US);
C07C41/16 (EP,US);
C07C45/00 (EP,US);
C07C45/513 (EP,US);
C07C45/562 (EP,US);
C07C49/697 (EP,US);
C07C49/747 (EP,US);
C07C49/755 (EP,US);
C07C49/792 (KR);
C07C59/255 (EP,US);
C07D215/00 (KR);
| C-Set: |
C07C227/16, C07C229/46 (US,EP);
C07C41/16, C07C43/202 (EP,US);
C07C45/00, C07C49/697 (EP,US);
C07C45/513, C07C49/67 (US,EP); | Designated contracting states | DE, FR, GB, IT [2000/34] |
Former [1993/11] | AT, BE, CH, DE, DK, FR, GB, IE, IT, LI, LU, NL, PT, SE | Title | German: | Benzo(f)quinolinone als 5-Alpha-reductase Inhibitoren | [1993/11] | English: | Benzo(f)quinolinones as 5-alpha-reductase inhibitors | [2000/15] | French: | Benzo(f)quinolinones comme inhibiteurs de 5-alpha-réductase | [1993/11] |
Former [1993/11] | Benzo f quinolinones as 5-alpha-reductase inhibitors | Examination procedure | 20.08.1992 | Examination requested [1993/11] | 29.01.1997 | Despatch of a communication from the examining division (Time limit: M06) | 07.07.1997 | Reply to a communication from the examining division | 13.01.1998 | Despatch of a communication from the examining division (Time limit: M06) | 22.07.1998 | Reply to a communication from the examining division | 16.11.1998 | Despatch of a communication from the examining division (Time limit: M04) | 23.04.1999 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 15.06.1999 | Reply to a communication from the examining division | 02.07.1999 | Despatch of a communication from the examining division (Time limit: M06) | 12.01.2000 | Reply to a communication from the examining division | 06.04.2000 | Despatch of communication of intention to grant (Approval: Yes) | 06.07.2000 | Communication of intention to grant the patent | 28.08.2000 | Fee for grant paid | 28.08.2000 | Fee for publishing/printing paid | Opposition(s) | 28.09.2001 | No opposition filed within time limit [2001/51] | Request for further processing for: | 15.06.1999 | Request for further processing filed | 15.06.1999 | Full payment received (date of receipt of payment) Request granted | 30.06.1999 | Decision despatched | Fees paid | Renewal fee | 05.07.1994 | Renewal fee patent year 03 | 07.07.1995 | Renewal fee patent year 04 | 26.07.1996 | Renewal fee patent year 05 | 21.07.1997 | Renewal fee patent year 06 | 04.07.1998 | Renewal fee patent year 07 | 10.08.1999 | Renewal fee patent year 08 | 07.08.2000 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0127597 (ASTRA LAEKEMEDEL AB [SE]); | [A]EP0399159 (HOFFMANN LA ROCHE [CH]) | [ ] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 7, July 1990, pages 2000-2006, American Chemical Society, US; J.G. CANNON et al.: "Monomethyl ether derivatives of 7,8-dihydroxy- and 8,9-dihydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines as possible products of metabolism by catechol-O-methyltransferase" | [ ] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 22, no. 4, April 1979, pages 341-347, American Chemical Society, US; J.G. CANNON et al.: "Rigid congeners of dopamine based on octahydrobenzo(f)quinoline: peripheral and central effects" | [ ] - SYNTHESIS, no. 6, June 1986, pages 494-496, Georg Thieme Verlag, Stuttgart, DE; J.G. CANNON et al.: "Stereospecific route to trans-1,2,3,4a,5,6,10b-octahydrobenzo(f)quinolines" | [ ] - JOURNAL OF MEDICINAL CHEMISTRY vol. 33, no. 7, July 1990, WASHINGTON pages 2000 - 2006 J.G. CANNON ET. AL. | [ ] - JOURNAL OF CHEMISTRY vol. 22, no. 4, April 1979, WASHINGTON pages 341 - 347 J. G. CANNON ET. AL. | [ ] - SYNTHESIS no. 6, June 1986, STUTTGART pages 494 - 496 J. G. CANNON ET. AL. | Examination | - TETRAHEDRON LETTERS vol. 29, no. 35, 1988, OXFORD pages 4427 - 4430 JEAN D¡ANGELO ET. AL. | - TETRAHEDRON LETTERS vol. 28, no. 21, 1987, OXFORD pages 2367 - 2370 TONY VOLPE ET. AL. | - CHEMICAL ABSTRACTS, vol. 78, no. 11, 19 March 1973, Columbus, Ohio, US; abstract no. 71780a, page 441 ;column R ; |